FDA Drug Recalls

Recalls / Class II

Class IID-675-2013

Product

Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

Affected lot / code info
Lot number CABCACBA:23, Exp date: 3/31/2013 and Lot number CABDAIAD:13, Exp date: 9/4/2013.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Recalling firm

Firm
Clinical Specialties Compounding Pharmacy
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
318 Baston Rd, N/A, Augusta, Georgia 30907

Distribution

Quantity
13ml
Distribution pattern
FL, GA and SC.

Timeline

Recall initiated
2013-03-20
FDA classified
2013-07-03
Posted by FDA
2013-07-10
Terminated
2017-02-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-675-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls